Cinqair (reslizumab; Teva) Drug Overview 2018 - ResearchAndMarkets.com


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


The "Drug Overview: Cinqair" report has been added to ResearchAndMarkets.com's offering.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Cinqair (reslizumab; Teva) is a humanized monoclonal antibody which targets interleukin (IL)-5. IL-5 has been shown to play a key role in the maturation, growth, and chemotaxis of eosinophils, which are inflammatory white blood cells implicated in a number of allergic diseases, including asthma. Cinqair gained US and EU approvals for use in asthma in an IV formulation in March 2016 and August 2016, respectively. Teva is also developing a subcutaneous formulation of Cinqair, which is in Phase III.

Key Topics Covered:

List of Figures

Drug assessment summary of Xolair in asthma

Xolair sales for asthma across the US, Japan, and five major EU markets, by country, 2017-26


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Cinqair sales for asthma across the US and five major EU markets, by country, 2017-26

List of Tables

Cinqair drug profile

Cinqair pivotal Phase III data in asthma

Cinqair sales for asthma across the US and five major EU markets, by country (NYSE:M), 2017-26

For more information about this report visit https://www.researchandmarkets.com/research/fxzcsf/cinqair?w=4


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Press Releases